Actively Recruiting
Discharge Medication Use Post-Operatively in GU Cancer Patients
Led by Wake Forest University Health Sciences · Updated on 2026-01-22
684
Participants Needed
1
Research Sites
122 weeks
Total Duration
On this page
Sponsors
W
Wake Forest University Health Sciences
Lead Sponsor
A
Atrium Health Levine Cancer Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.
CONDITIONS
Official Title
Discharge Medication Use Post-Operatively in GU Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent and HIPAA authorization for release of personal health information.
- Age ≥ 18 years at the time of enrollment
- Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
- Ability to read and understand the English and/or Spanish language.
- As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Levine Cancer Institute
Charlotte, North Carolina, United States, 28204
Actively Recruiting
Research Team
M
Margarita Dzhanumova
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here